DaVita Price to Book Ratio 2010-2024 | DVA
Historical price to book ratio values for DaVita (DVA) over the last 10 years. The current price to book ratio for DaVita as of December 20, 2024 is 20.62.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| DaVita Price/Book Ratio Historical Data |
| Date |
Stock Price |
Book Value per Share |
Price to Book Ratio |
| 2024-12-20 |
151.85 |
|
21.39 |
| 2024-09-30 |
163.93 |
$7.10 |
23.09 |
| 2024-06-30 |
138.57 |
$9.99 |
13.87 |
| 2024-03-31 |
138.05 |
$12.91 |
10.69 |
| 2023-12-31 |
104.76 |
$14.01 |
7.48 |
| 2023-09-30 |
94.53 |
$15.10 |
6.26 |
| 2023-06-30 |
100.47 |
$13.21 |
7.60 |
| 2023-03-31 |
81.11 |
$11.25 |
7.21 |
| 2022-12-31 |
74.67 |
$9.69 |
7.71 |
| 2022-09-30 |
82.77 |
$7.79 |
10.62 |
| 2022-06-30 |
79.96 |
$8.41 |
9.51 |
| 2022-03-31 |
113.11 |
$10.69 |
10.58 |
| 2021-12-31 |
113.76 |
$9.62 |
11.82 |
| 2021-09-30 |
116.26 |
$12.88 |
9.03 |
| 2021-06-30 |
120.43 |
$13.85 |
8.70 |
| 2020-12-31 |
117.40 |
$14.25 |
8.24 |
| 2020-09-30 |
85.65 |
$15.41 |
5.56 |
| 2020-06-30 |
79.14 |
$19.13 |
4.14 |
| 2020-03-31 |
76.06 |
$17.51 |
4.34 |
| 2019-12-31 |
75.03 |
$18.43 |
4.07 |
| 2021-03-31 |
107.77 |
$13.38 |
8.05 |
| 2019-09-30 |
57.07 |
$18.77 |
3.04 |
| 2019-06-30 |
56.26 |
$25.80 |
2.18 |
| 2019-03-31 |
54.29 |
$24.56 |
2.21 |
| 2018-12-31 |
51.46 |
$23.49 |
2.19 |
| 2018-09-30 |
71.63 |
$24.28 |
2.95 |
| 2018-06-30 |
69.44 |
$26.25 |
2.65 |
| 2018-03-31 |
65.94 |
$26.80 |
2.46 |
| 2017-12-31 |
72.25 |
$26.78 |
2.70 |
| 2017-09-30 |
59.39 |
$26.26 |
2.26 |
| 2017-06-30 |
64.76 |
$27.57 |
2.35 |
| 2017-03-31 |
67.97 |
$27.44 |
2.48 |
| 2016-12-31 |
64.20 |
$24.93 |
2.58 |
| 2016-09-30 |
66.07 |
$25.50 |
2.59 |
| 2016-06-30 |
77.32 |
$23.97 |
3.23 |
| 2016-03-31 |
73.38 |
$23.85 |
3.08 |
| 2015-12-31 |
69.71 |
$24.24 |
2.88 |
| 2015-09-30 |
72.33 |
$24.61 |
2.94 |
| 2015-06-30 |
79.47 |
$24.82 |
3.20 |
| 2015-03-31 |
81.28 |
$24.04 |
3.38 |
| 2014-12-31 |
75.74 |
$24.86 |
3.05 |
| 2014-09-30 |
73.14 |
$23.97 |
3.05 |
| 2014-06-30 |
72.32 |
$23.08 |
3.13 |
| 2014-03-31 |
68.85 |
$22.60 |
3.05 |
| 2013-12-31 |
63.37 |
$21.61 |
2.93 |
| 2013-09-30 |
56.90 |
$20.87 |
2.73 |
| 2013-06-30 |
60.40 |
$20.15 |
3.00 |
| 2013-03-31 |
59.30 |
$18.72 |
3.17 |
| 2012-12-31 |
55.27 |
$18.56 |
2.98 |
| 2012-09-30 |
51.81 |
$14.00 |
3.70 |
| 2012-06-30 |
49.11 |
$13.27 |
3.70 |
| 2012-03-31 |
45.09 |
$12.78 |
3.53 |
| 2011-12-31 |
37.91 |
$12.11 |
3.13 |
| 2011-09-30 |
31.34 |
$11.14 |
2.81 |
| 2011-06-30 |
43.31 |
$10.41 |
4.16 |
| 2011-03-31 |
42.76 |
$11.08 |
3.86 |
| 2010-12-31 |
34.75 |
$10.61 |
3.27 |
| 2010-09-30 |
34.52 |
$11.73 |
2.94 |
| 2010-06-30 |
31.22 |
$11.49 |
2.72 |
| 2009-12-31 |
29.37 |
$10.64 |
2.76 |
| 2009-09-30 |
28.32 |
$10.36 |
2.73 |
| 2009-06-30 |
24.73 |
$9.89 |
2.50 |
| 2009-03-31 |
21.98 |
$9.30 |
2.36 |
| 2010-03-31 |
31.70 |
$11.17 |
2.84 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Outpatient & Home Care |
$12.098B |
$12.140B |
|
DaVita Inc. is a leading provider of dialysis services in the U.S. to patients suffering from chronic kidney failure, also known as end-stage renal disease (ESRD). The company operates kidney dialysis centers and provides related medical services primarily in dialysis centers and in contracted hospitals across the U.S. Its services include outpatient dialysis services, hospital inpatient dialysis services and ancillary services such as ESRD laboratory services and disease management services. DaVita's Dialysis and related lab services business segment provides inpatient as well as outpatient dialysis services, routine laboratory testing for ESRD patients and management services to outpatient dialysis centers. The company's other ancillary services and strategic initiatives segment includes its international dialysis services, pharmacy services, infusion therapy services, disease management services, vascular access services, ESRD clinical research programs and physician services.
|
